BAUSCH + LOMB CORP (BLCO) Stock Fundamental Analysis

NYSE:BLCO • CA0717051076

17.8176 USD
-0.12 (-0.68%)
Last: Feb 23, 2026, 01:26 PM
Fundamental Rating

3

BLCO gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 185 industry peers in the Health Care Equipment & Supplies industry. BLCO has a medium profitability rating, but doesn't score so well on its financial health evaluation. BLCO has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • BLCO had positive earnings in the past year.
  • In the past year BLCO had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: BLCO reported negative net income in multiple years.
  • BLCO had a positive operating cash flow in 4 of the past 5 years.
BLCO Yearly Net Income VS EBIT VS OCF VS FCFBLCO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M 600M 800M

1.2 Ratios

  • With a decent Return On Assets value of -2.57%, BLCO is doing good in the industry, outperforming 69.73% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of -5.58%, BLCO is in the better half of the industry, outperforming 70.27% of the companies in the same industry.
  • The Return On Invested Capital of BLCO (1.23%) is better than 65.95% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for BLCO is significantly below the industry average of 8.75%.
Industry RankSector Rank
ROA -2.57%
ROE -5.58%
ROIC 1.23%
ROA(3y)-2.29%
ROA(5y)-1.02%
ROE(3y)-4.76%
ROE(5y)-2.45%
ROIC(3y)1.34%
ROIC(5y)1.76%
BLCO Yearly ROA, ROE, ROICBLCO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 0 2 -2 -4

1.3 Margins

  • BLCO has a Operating Margin of 3.69%. This is in the better half of the industry: BLCO outperforms 67.03% of its industry peers.
  • BLCO's Operating Margin has declined in the last couple of years.
  • Looking at the Gross Margin, with a value of 59.81%, BLCO is in the better half of the industry, outperforming 60.54% of the companies in the same industry.
  • BLCO's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 3.69%
PM (TTM) N/A
GM 59.81%
OM growth 3Y-17.35%
OM growth 5Y-14.11%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.07%
GM growth 5Y-0.82%
BLCO Yearly Profit, Operating, Gross MarginsBLCO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

1

2. Health

2.1 Basic Checks

  • BLCO has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for BLCO has been increased compared to 1 year ago.
  • BLCO has more shares outstanding than it did 5 years ago.
  • BLCO has a worse debt/assets ratio than last year.
BLCO Yearly Shares OutstandingBLCO Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
BLCO Yearly Total Debt VS Total AssetsBLCO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 5B 10B

2.2 Solvency

  • BLCO has an Altman-Z score of 0.91. This is a bad value and indicates that BLCO is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of 0.91, BLCO perfoms like the industry average, outperforming 50.27% of the companies in the same industry.
  • A Debt/Equity ratio of 0.78 indicates that BLCO is somewhat dependend on debt financing.
  • BLCO's Debt to Equity ratio of 0.78 is on the low side compared to the rest of the industry. BLCO is outperformed by 69.73% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF N/A
Altman-Z 0.91
ROIC/WACC0.12
WACC10.25%
BLCO Yearly LT Debt VS Equity VS FCFBLCO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B 8B

2.3 Liquidity

  • A Current Ratio of 1.55 indicates that BLCO should not have too much problems paying its short term obligations.
  • BLCO has a Current ratio of 1.55. This is in the lower half of the industry: BLCO underperforms 73.51% of its industry peers.
  • A Quick Ratio of 1.04 indicates that BLCO should not have too much problems paying its short term obligations.
  • With a Quick ratio value of 1.04, BLCO is not doing good in the industry: 75.68% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.55
Quick Ratio 1.04
BLCO Yearly Current Assets VS Current LiabilitesBLCO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

4

3. Growth

3.1 Past

  • The earnings per share for BLCO have decreased strongly by -19.35% in the last year.
  • The Revenue has been growing slightly by 6.47% in the past year.
  • BLCO shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.38% yearly.
EPS 1Y (TTM)-19.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28%
Revenue 1Y (TTM)6.47%
Revenue growth 3Y10.62%
Revenue growth 5Y8.38%
Sales Q2Q%9.77%

3.2 Future

  • BLCO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 32.47% yearly.
  • Based on estimates for the next years, BLCO will show a small growth in Revenue. The Revenue will grow by 3.83% on average per year.
EPS Next Y60.98%
EPS Next 2Y47.19%
EPS Next 3Y40.75%
EPS Next 5Y32.47%
Revenue Next Year5.85%
Revenue Next 2Y5.67%
Revenue Next 3Y5%
Revenue Next 5Y3.83%

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BLCO Yearly Revenue VS EstimatesBLCO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B
BLCO Yearly EPS VS EstimatesBLCO Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0.5 1 1.5 2

4

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 35.64 indicates a quite expensive valuation of BLCO.
  • Based on the Price/Earnings ratio, BLCO is valued a bit cheaper than 71.89% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of BLCO to the average of the S&P500 Index (26.99), we can say BLCO is valued slightly more expensively.
  • With a Price/Forward Earnings ratio of 22.14, BLCO is valued on the expensive side.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of BLCO indicates a somewhat cheap valuation: BLCO is cheaper than 77.84% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of BLCO to the average of the S&P500 Index (28.02), we can say BLCO is valued slightly cheaper.
Industry RankSector Rank
PE 35.64
Fwd PE 22.14
BLCO Price Earnings VS Forward Price EarningsBLCO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BLCO indicates a somewhat cheap valuation: BLCO is cheaper than 76.22% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 18.15
BLCO Per share dataBLCO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as BLCO's earnings are expected to grow with 40.75% in the coming years.
PEG (NY)0.58
PEG (5Y)N/A
EPS Next 2Y47.19%
EPS Next 3Y40.75%

0

5. Dividend

5.1 Amount

  • No dividends for BLCO!.
Industry RankSector Rank
Dividend Yield 0%

BAUSCH + LOMB CORP

NYSE:BLCO (2/23/2026, 1:26:09 PM)

17.8176

-0.12 (-0.68%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-18
Earnings (Next)N/A
Inst Owners11.05%
Inst Owner Change3.17%
Ins Owners0.45%
Ins Owner Change4.16%
Market Cap6.31B
Revenue(TTM)5.10B
Net Income(TTM)-360.00M
Analysts72.63
Price Target17.68 (-0.77%)
Short Float %8.7%
Short Ratio10.01
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.14%
Min EPS beat(2)-10.76%
Max EPS beat(2)8.47%
EPS beat(4)2
Avg EPS beat(4)-90.21%
Min EPS beat(4)-360.35%
Max EPS beat(4)8.47%
EPS beat(8)5
Avg EPS beat(8)-43.92%
EPS beat(12)8
Avg EPS beat(12)-25.31%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.1%
Min Revenue beat(2)-1.91%
Max Revenue beat(2)-0.28%
Revenue beat(4)0
Avg Revenue beat(4)-1.41%
Min Revenue beat(4)-3.07%
Max Revenue beat(4)-0.28%
Revenue beat(8)2
Avg Revenue beat(8)-0.31%
Revenue beat(12)5
Avg Revenue beat(12)0.68%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.97%
PT rev (3m)4.32%
EPS NQ rev (1m)3.86%
EPS NQ rev (3m)-1.08%
EPS NY rev (1m)0.21%
EPS NY rev (3m)0.88%
Revenue NQ rev (1m)0.14%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)-0.04%
Valuation
Industry RankSector Rank
PE 35.64
Fwd PE 22.14
P/S 1.24
P/FCF N/A
P/OCF 22.31
P/B 0.98
P/tB N/A
EV/EBITDA 18.15
EPS(TTM)0.5
EY2.81%
EPS(NY)0.8
Fwd EY4.52%
FCF(TTM)-0.19
FCFYN/A
OCF(TTM)0.8
OCFY4.48%
SpS14.4
BVpS18.2
TBVpS-4.49
PEG (NY)0.58
PEG (5Y)N/A
Graham Number14.31
Profitability
Industry RankSector Rank
ROA -2.57%
ROE -5.58%
ROCE 1.55%
ROIC 1.23%
ROICexc 1.27%
ROICexgc 4.04%
OM 3.69%
PM (TTM) N/A
GM 59.81%
FCFM N/A
ROA(3y)-2.29%
ROA(5y)-1.02%
ROE(3y)-4.76%
ROE(5y)-2.45%
ROIC(3y)1.34%
ROIC(5y)1.76%
ROICexc(3y)1.38%
ROICexc(5y)1.81%
ROICexgc(3y)4.6%
ROICexgc(5y)6.09%
ROCE(3y)1.7%
ROCE(5y)2.22%
ROICexgc growth 3Y-15.27%
ROICexgc growth 5Y-11.42%
ROICexc growth 3Y-14.77%
ROICexc growth 5Y-9.61%
OM growth 3Y-17.35%
OM growth 5Y-14.11%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.07%
GM growth 5Y-0.82%
F-Score3
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF N/A
Debt/EBITDA 8.28
Cap/Depr 82.9%
Cap/Sales 6.84%
Interest Coverage 0.49
Cash Conversion 46.47%
Profit Quality N/A
Current Ratio 1.55
Quick Ratio 1.04
Altman-Z 0.91
F-Score3
WACC10.25%
ROIC/WACC0.12
Cap/Depr(3y)65.67%
Cap/Depr(5y)57.94%
Cap/Sales(3y)5.76%
Cap/Sales(5y)5.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-19.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28%
EPS Next Y60.98%
EPS Next 2Y47.19%
EPS Next 3Y40.75%
EPS Next 5Y32.47%
Revenue 1Y (TTM)6.47%
Revenue growth 3Y10.62%
Revenue growth 5Y8.38%
Sales Q2Q%9.77%
Revenue Next Year5.85%
Revenue Next 2Y5.67%
Revenue Next 3Y5%
Revenue Next 5Y3.83%
EBIT growth 1Y-7.39%
EBIT growth 3Y-8.57%
EBIT growth 5Y-6.91%
EBIT Next Year60.48%
EBIT Next 3Y27.19%
EBIT Next 5Y16.65%
FCF growth 1Y-11.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y21.98%
OCF growth 3Y-6.39%
OCF growth 5Y-11.52%

BAUSCH + LOMB CORP / BLCO FAQ

What is the fundamental rating for BLCO stock?

ChartMill assigns a fundamental rating of 3 / 10 to BLCO.


What is the valuation status of BAUSCH + LOMB CORP (BLCO) stock?

ChartMill assigns a valuation rating of 4 / 10 to BAUSCH + LOMB CORP (BLCO). This can be considered as Fairly Valued.


Can you provide the profitability details for BAUSCH + LOMB CORP?

BAUSCH + LOMB CORP (BLCO) has a profitability rating of 4 / 10.


What is the financial health of BAUSCH + LOMB CORP (BLCO) stock?

The financial health rating of BAUSCH + LOMB CORP (BLCO) is 1 / 10.